Departments of Dermatology and.
Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA.
Br J Dermatol. 2023 Aug 24;189(3):338-354. doi: 10.1093/bjd/ljad138.
Current validated hidradenitis suppurativa (HS) severity assessment tools are time-consuming and impractical in fast-paced, ambulatory clinic settings. This study evaluated the construct validity of the most severe or ‘worst’ area local Hidradenitis suppurativa Activity and Severity Index-Revised (W-HASI-R) as a novel target area assessment tool for clinical setting use. W-HASI-R had strong association with the International Hidradenitis Suppurativa Severity Score System and abscess and nodule count, moderate association with Hurley stage and HS physician global assessment and weak, negative association with reverse-scored Dermatology Quality Life Index. The resulting data suggest that W-HASI-R may be an option as an efficient target area assessment tool for fast-paced, ambulatory settings.
目前已验证的化脓性汗腺炎（HS）严重程度评估工具在快节奏的门诊环境中既耗时又不切实际。本研究评估了最严重或“最差”部位局部化脓性汗腺炎活动和严重程度修订指数（W-HASI-R）作为一种新的临床应用目标区域评估工具的结构效度。W-HASI-R 与国际化脓性汗腺炎严重程度评分系统以及脓肿和结节计数有很强的关联性，与 Hurley 分期和化脓性汗腺炎医生总体评估有中度关联性，与反向评分皮肤病生活质量指数有较弱的负关联性。所得数据表明，W-HASI-R 可能是一种有效的目标区域评估工具，适用于快节奏的门诊环境。
